A murine passive transfer model system was employed to ascertain the effects of gestational exposure to a single, intravenous dose of purified, brain-reactive IgG antibodies from individual mothers of children with autism (MAU) or mothers with typically developing children (MTD). Growth and behavioral outcomes in offspring were measured from postnatal days 8 to 65 in each group. Comparisons revealed alterations in early growth trajectories, significantly impaired motor and sensory development, and increased anxiety. This report demonstrates for the first time the effects of a single, low dose gestational exposure of IgG derived from individual MAU on their offspring's physical and social development.
Introduction
Autism spectrum disorders (ASD) is comprised of a heterogeneous group of behaviorally defined neurodevelopmental disorders that manifest as impairments in three core domains: verbal and non-verbal communication, social reciprocity, and repetitive behaviors. Within ASD, diagnoses of autistic disorder (AU), Asperger syndrome (AS) and pervasive developmental disorder-not otherwise specified (PDD-NOS) are applied based on symptom presentation and severity. Current prevalence estimates of 1 per 88 live births in the United States (CDC, 2012) and a lack of identified causative factors in most cases have fostered much effort towards identifying risk factors for ASD. Although clinical diagnosis is typically made near three years of age, current evidence suggests that the underlying neurodevelopmental changes may occur much earlier, likely in utero. Of the numerous maternal factors that enter fetal circulation during gestation, an etiologic role for brainreactive IgG antibodies in ASD has now received support in several studies (Dalton et al., 2003; Braunschweig et al., 2008; Martin et al., 2008; Singer et al., 2008; Braunschweig et al., 2012) .
Prior to maturation of the mammalian immune system, adaptive immune protection is transferred from mother to fetus via IgG isotype antibodies. In pregnant mice, as well as in humans, specific placental Fc receptors actively transport maternal IgG into the fetal circulation (Kim et al., 2009 ). These maternal IgG antibodies are known to confer specific immunity on offspring and represent the primary adaptive immunity in the neonate. Antibodies are also transferred postnatally through lactation in both humans and mice (Van de Perre, 2003) . Additional non-immune developmental functions of maternal IgG have also been suggested from experimental results in mouse models (Gustafsson et al., 1994) , although the precise mechanisms of these remain unclear.
Several deleterious consequences of in utero maternal antibody transfer have been described for autoimmune diseases such as systemic lupus erythematosus (Lee et al., 2009 ) and arthrogryposis multiplex congenita syndrome arising from myasthenia gravis in the mother (Jacobson et al., 1998) . Experimentally, models of passive IgG transfer of human lupus autoantibodies to pregnant mice have replicated significant aspects of the congenital heart block noted in human newborns, supporting a causal role for these antibodies in that disorder (Tran et al., 2002) .
Maternal antibodies associated with ASD were first observed over 20 years ago (Warren et al., 1990) and several descriptive behavioral Journal of Neuroimmunology 252 (2012) 56-65 
